Associated Papers
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1.
Engelmann C et al.
Cell Death & Disease, 2022
36270981 (PubMed )
Supplement: 41419_2022_5337_MOESM9_ESM.xlsx › Sheet1
Molecular modeling in the age of clinical genomics, the enterprise of the next generation.
Prokop JW et al.
Journal of Molecular Modeling, 2017
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
Damgaard RB et al.
Embo Molecular Medicine, 2013
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
Marsh RA et al.
Blood, 2010
HAMP promoter mutation nc.-153C>T in non p.C282Y homozygous patients with iron overload.
Aguilar-Martinez P et al.
Haematologica, 2010
A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly.
Zhao M et al.
Haematologica, 2010
A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
Marsh RA et al.
Cytometry. Part B, Clinical Cytometry, 2009
Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations.
Marsh RA et al.
Clinical Immunology (orlando, Fla.), 2009
Select a paper to view details